The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Besides Wall Street's top -and-bottom-line estimates for Illumina (ILMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. Read More on ILMN: Illumina NewsMORE Related Stocks Indices ...

Wall Street analysts forecast that Illumina (ILMN) will report quarterly ... It is projected by analysts that the 'Revenue- Microarrays- Instruments' will reach $4.20 million.

The global genomics market is experiencing significant growth due to advancements in technologies like Next-Generation Sequencing (NGS) and microarrays. Companies like Illumina, Complete Genomics ...

Companies like Complete Genomics, Illumina, and Singular Genomics Systems lead the ... Sensitive instruments, such as flow cytometry and microarrays, are essential tools. Janssen, Life Sciences Vision ...